tickdelta
tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

DXCMDexcom

Health care · Medical Instruments · Nasdaq
DXCM quote by TradingView
Compare with peers → Embed
FY2025 at a glance

Sales up 15.6%, free cash flow up to $1.1B

XBRL, from each 10-K
RevenueStatements ↓
$4.7B
from $4.0B in FY2024
FY2016FY2025
Net incomeStatements ↓
$836.3M
from $576.2M in FY2024
FY2016FY2025
Free cash flowStatements ↓
$1.1B
from $630.7M in FY2024
FY2016FY2025
EPS (diluted)Statements ↓
$2.09
from $1.42 in FY2024
FY2016FY2025
Operating marginStatements ↓
19.6%
from 14.9% in FY2024
FY2016FY2025
Price and key numbers

The latest figures

All key numbers (40, from the latest 10-K and 10-Q) From EDGAR
EPS (ttm)2.54Sales (ttm)5.1BNet income (ttm)991.0MSales growth+15.6%EPS growth+47.2%Sales Q/Q+11.2%
Free cash flow1.1BGross margin63.4%Oper. margin24.0%Net margin19.4%FCF margin21.5%ROE39.1%
ROA15.9%R&D / sales12.9%Dividend-Debt/Eq-Curr. ratio1.74Cash961.4M
Op. cash flow (ttm)1.4BEBITDA1.2BEBITDA margin25.0%Quick ratio1.46Interest cover49.83ROIC27.6%
Tax rate23.2%Stock pay / sales3.4%Shares out.373.0MShares Y/Y-1.7%Book / share6.80Cash / share2.58
Sales / share13.69Asset turnover0.82Inventory turns2.96Days sales out.95Sales 3Y CAGR+17.0%Sales 5Y CAGR+19.3%
EPS 3Y CAGR+36.6%EPS 5Y CAGR+9.5%Employees11,100Sales / employee460K

Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.

Changes in the numbers

FY2025 against FY2024
  • Free cash flow rose 71%$630.7M → $1.1B · Cash from operations − capital expenditure · 10-K ↗
  • Operating margin widened to 19.6%14.9% → 19.6% · Operating income / revenue · 10-K ↗
What management wrote about it → · Every company →

DXCM against Health care peers

Ten years, side by side → · All 60 →
GrowthProfitBalanceCleanInsiders
DXCMPeer median

Each side 0 to 100, ranked against every company we cover: relative position on reported figures, not a buy score. How

Every dot is one of the 60 companies, the better end on the right. Hover a dot for the company.

Sales growth
+15.6%8th of 60 · median +7.1%
Net margin
19.4%13th of 60 · median 9.6%
Return on equity
39.1%7th of 54 · median 13.1%
Free cash flow margin
21.5%14th of 56 · median 15.5%
DXCM and the 5 peers closest in revenue
CompanyRevenue (ttm)Sales growthGross marginNet marginROEFCF marginDebt / equity
DXCM Dexcom$5.1B +15.6%63.4%19.4%39.1%21.5%-
RMD ResMed$5.7B +9.9%61.1%27.8%26.8%28.1%0.07
IDXX Idexx Laboratories$4.7B +10.4%62.7%25.4%63.2%28.0%0.20
WAT Waters Corporation$4.6B +7.0%59.3%3.6%1.1%8.6%0.33
ILMN Illumina, Inc.$4.5B -0.7%67.9%19.7%28.5%23.3%0.57
COO Cooper Companies$4.2B +5.1%65.9%13.5%6.8%16.0%0.31
Where each dollar goes

From $2.4B of sales to $216.9M of profit

FY2021, from the 10-K income statement
Revenue to Gross profit: $1.7BRevenue to Cost of revenue: $768.0MGross profit to Operating profit: $265.8MGross profit to Operating expenses: $1.4BOperating profit to Net profit: $216.9MOperating profit to Tax & other: $48.9MOperating expenses to R&D: $517.1MOperating expenses to Sales, admin & other: $897.6M Revenue: $2.4B Revenue$2.4B +27% Y/Y Gross profit: $1.7B · 69% margin Gross profit$1.7B69% margin +31% Y/Y Cost of revenue: $768.0M · 31% of revenue Cost of revenue$768.0M31% of revenue Operating profit: $265.8M · 11% margin Operating profit$265.8M11% margin −11% Y/Y Operating expenses: $1.4B · 58% of revenue Operating expenses$1.4B58% of revenue Net profit: $216.9M · 9% margin Net profit$216.9M9% margin −61% Y/Y Tax & other: $48.9M · 2% of revenue Tax & other$48.9M2% of revenue R&D: $517.1M · 21% of revenue R&D$517.1M21% of revenue Sales, admin & other: $897.6M · 37% of revenue Sales, admin & other$897.6M37% of revenue

Swipe sideways for the whole flow →

From $2.9B of sales to $341.2M of profit

FY2022, from the 10-K income statement and revenue by region
United States to Revenue: $2.1BInternational to Revenue: $767.8MRevenue to Gross profit: $1.9BRevenue to Cost of revenue: $1.0BGross profit to Operating profit: $391.2MGross profit to Operating expenses: $1.5BOperating profit to Net profit: $341.2MOperating profit to Tax: $50.0MOperating expenses to R&D: $484.2MOperating expenses to SG&A: $1.0B United States: $2.1B · 74% United States$2.1B74% International: $767.8M · 26% International$767.8M26% Revenue: $2.9B Revenue$2.9B +19% Y/Y Gross profit: $1.9B · 65% margin Gross profit$1.9B65% margin +12% Y/Y Cost of revenue: $1.0B · 35% of revenue Cost of revenue$1.0B35% of revenue Operating profit: $391.2M · 13% margin Operating profit$391.2M13% margin +47% Y/Y Operating expenses: $1.5B · 51% of revenue Operating expenses$1.5B51% of revenue Net profit: $341.2M · 12% margin Net profit$341.2M12% margin +57% Y/Y Tax: $50.0M · 2% of revenue Tax$50.0M2% of revenue R&D: $484.2M · 17% of revenue R&D$484.2M17% of revenue SG&A: $1.0B · 35% of revenue SG&A$1.0B35% of revenue

Swipe sideways for the whole flow →

From $3.6B of sales to $541.5M of profit

FY2023, from the 10-K income statement and revenue by region
United States to Revenue: $2.6BInternational to Revenue: $997.0MRevenue to Gross profit: $2.3BRevenue to Cost of revenue: $1.3BGross profit to Operating profit: $597.7MGross profit to Operating expenses: $1.7BOperating profit to Net profit: $428.8MOperating profit to Tax: $168.9MOther income to Net profit: $112.7MOperating expenses to R&D: $505.8MOperating expenses to SG&A: $1.2B United States: $2.6B · 72% United States$2.6B72% International: $997.0M · 28% International$997.0M28% Revenue: $3.6B Revenue$3.6B +24% Y/Y Gross profit: $2.3B · 63% margin Gross profit$2.3B63% margin +22% Y/Y Cost of revenue: $1.3B · 37% of revenue Cost of revenue$1.3B37% of revenue Operating profit: $597.7M · 17% margin Operating profit$597.7M17% margin +53% Y/Y Other income: $112.7M · 3% of revenue Other income$112.7M3% of revenue Operating expenses: $1.7B · 47% of revenue Operating expenses$1.7B47% of revenue Net profit: $541.5M · 15% margin Net profit$541.5M15% margin +59% Y/Y Tax: $168.9M · 5% of revenue Tax$168.9M5% of revenue R&D: $505.8M · 14% of revenue R&D$505.8M14% of revenue SG&A: $1.2B · 33% of revenue SG&A$1.2B33% of revenue

Swipe sideways for the whole flow →

From $4.0B of sales to $576.2M of profit

FY2024, from the 10-K income statement and revenue by region
United States to Revenue: $2.9BInternational to Revenue: $1.1BRevenue to Gross profit: $2.4BRevenue to Cost of revenue: $1.6BGross profit to Operating profit: $600.0MGross profit to Operating expenses: $1.8BOperating profit to Net profit: $467.2MOperating profit to Tax: $132.8MOther income to Net profit: $109.0MOperating expenses to R&D: $552.4MOperating expenses to SG&A: $1.3B United States: $2.9B · 72% United States$2.9B72% International: $1.1B · 28% International$1.1B28% Revenue: $4.0B Revenue$4.0B +11% Y/Y Gross profit: $2.4B · 60% margin Gross profit$2.4B60% margin +7% Y/Y Cost of revenue: $1.6B · 40% of revenue Cost of revenue$1.6B40% of revenue Operating profit: $600.0M · 15% margin Operating profit$600.0M15% margin +0% Y/Y Other income: $109.0M · 3% of revenue Other income$109.0M3% of revenue Operating expenses: $1.8B · 46% of revenue Operating expenses$1.8B46% of revenue Net profit: $576.2M · 14% margin Net profit$576.2M14% margin +6% Y/Y Tax: $132.8M · 3% of revenue Tax$132.8M3% of revenue R&D: $552.4M · 14% of revenue R&D$552.4M14% of revenue SG&A: $1.3B · 32% of revenue SG&A$1.3B32% of revenue

Swipe sideways for the whole flow →

From $4.7B of sales to $836.3M of profit

FY2025, from the 10-K income statement and revenue by region
United States to Revenue: $3.3BInternational to Revenue: $1.3BRevenue to Gross profit: $2.8BRevenue to Cost of revenue: $1.9BGross profit to Operating profit: $911.8MGross profit to Operating expenses: $1.9BOperating profit to Net profit: $659.7MOperating profit to Tax: $252.1MOther income to Net profit: $176.6MOperating expenses to R&D: $599.1MOperating expenses to SG&A: $1.3B United States: $3.3B · 72% United States$3.3B72% International: $1.3B · 28% International$1.3B28% Revenue: $4.7B Revenue$4.7B +16% Y/Y Gross profit: $2.8B · 60% margin Gross profit$2.8B60% margin +15% Y/Y Cost of revenue: $1.9B · 40% of revenue Cost of revenue$1.9B40% of revenue Operating profit: $911.8M · 20% margin Operating profit$911.8M20% margin +52% Y/Y Other income: $176.6M · 4% of revenue Other income$176.6M4% of revenue Operating expenses: $1.9B · 41% of revenue Operating expenses$1.9B41% of revenue Net profit: $836.3M · 18% margin Net profit$836.3M18% margin +45% Y/Y Tax: $252.1M · 5% of revenue Tax$252.1M5% of revenue R&D: $599.1M · 13% of revenue R&D$599.1M13% of revenue SG&A: $1.3B · 28% of revenue SG&A$1.3B28% of revenue

Swipe sideways for the whole flow →

Where each $100 of sales went

FY2021
FY2022
FY2023
FY2024
FY2025
  • Cost of revenue
  • R&D
  • Sales, admin & other
  • Tax, less other income
  • Net profit

Band widths are the money. Gross profit is revenue less cost of revenue; operating expenses are gross profit less operating profit; R&D is from the income statement and the rest of the operating expenses is everything else; tax includes interest and other items when they are small. Y/Y is the change from the fiscal year before. Revenue by part only for the years in the last two 10-Ks' segment tables. The full income statement →

Profitability

2 of 4
  • ✓
    Net margin above the peer median19.4% vs 9.6%
  • !
    Gross margin down over 5 years66.4% → 60.1%
  • ✓
    Return on equity above 15%39.1%
  • !
    A profit in 7 of 10 years
Net margin, FY2016 to FY2025: -11.4% → 17.9%

Balance sheet

2 of 2
  • ✓
    Interest covered more than 5 timesOperating income is 49.8× interest expense
  • ✓
    Current assets cover current liabilitiesCurrent ratio 1.74

Cash and shareholders

3 of 3
  • ✓
    Free cash flow positive in every one of 10 years$1.1B last year
  • ✓
    Share count down over 5 years−3.5%
  • ✓
    Cash from operations above net income$1.4B vs $836.3M
Free cash flow, FY2016 to FY2025: 500K → 1.1B

Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.

Revenue and net income, FY2016 to FY2025

Revenue 4.7B Net income 836.3M
FY2016 revenue 573.3M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001093557-19-000041 FY2016 net income -65.6M · NetIncomeLoss, 0001093557-19-000041 573.3M FY2016 FY2017 revenue 718.5M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001093557-20-000029 FY2017 net income -50.2M · NetIncomeLoss, 0001093557-20-000029 718.5M FY2017 FY2018 revenue 1.0B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001093557-21-000024 FY2018 net income -127.1M · NetIncomeLoss, 0001093557-21-000024 1.0B FY2018 FY2019 revenue 1.5B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001093557-22-000014 FY2019 net income 101.1M · NetIncomeLoss, 0001093557-22-000014 1.5B FY2019 FY2020 revenue 1.9B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001093557-23-000024 FY2020 net income 549.7M · NetIncomeLoss, 0001093557-23-000024 1.9B FY2020 FY2021 revenue 2.4B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001093557-24-000021 FY2021 net income 216.9M · NetIncomeLoss, 0001093557-24-000021 2.4B FY2021 FY2022 revenue 2.9B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001093557-25-000036 FY2022 net income 341.2M · NetIncomeLoss, 0001093557-25-000036 2.9B FY2022 FY2023 revenue 3.6B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001093557-26-000027 FY2023 net income 541.5M · NetIncomeLoss, 0001093557-26-000027 3.6B FY2023 FY2024 revenue 4.0B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001093557-26-000027 FY2024 net income 576.2M · NetIncomeLoss, 0001093557-26-000027 4.0B FY2024 FY2025 revenue 4.7B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001093557-26-000027 FY2025 net income 836.3M · NetIncomeLoss, 0001093557-26-000027 4.7B FY2025

From XBRL in each 10-K. Hover a bar for the line item and filing. Full financials →

Statements

Income statement, balance sheet and cash flow

XBRL, each 10-K and 10-Q

DXCM's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.

Annual Quarterly
Revenue4.7B
FY2016: 573.3MFY2017: 718.5MFY2018: 1.0BFY2019: 1.5BFY2020: 1.9BFY2021: 2.4BFY2022: 2.9BFY2023: 3.6BFY2024: 4.0BFY2025: 4.7B FY2017FY2019FY2021FY2023FY2025
Net income836.3M
FY2016: -65.6MFY2017: -50.2MFY2018: -127.1MFY2019: 101.1MFY2020: 549.7MFY2021: 216.9MFY2022: 341.2MFY2023: 541.5MFY2024: 576.2MFY2025: 836.3M FY2017FY2019FY2021FY2023FY2025
Free cash flow1.1B
FY2016: 500KFY2017: 26.0MFY2018: 56.1MFY2019: 134.5MFY2020: 276.6MFY2021: 53.3MFY2022: 304.7MFY2023: 511.9MFY2024: 630.7MFY2025: 1.1B FY2017FY2019FY2021FY2023FY2025
EPS (diluted)2.09
FY2016: -0.78FY2017: -0.58FY2018: -1.44FY2019: 1.10FY2020: 1.33FY2021: 0.53FY2022: 0.82FY2023: 1.30FY2024: 1.42FY2025: 2.09 FY2017FY2019FY2021FY2023FY2025
Diluted shares405.5M
FY2016: -FY2017: 86.3MFY2018: 88.2MFY2019: 92.3MFY2020: 420.4MFY2021: 428.8MFY2022: 427.5MFY2023: 425.5MFY2024: 412.7MFY2025: 405.5M FY2017FY2019FY2021FY2023FY2025

Revenue by region

year to Dec 31, 2025
RevenueSharevs year before
United States 3.3B71.5% +15.4%
International 1.3B28.5% +16.1%

10-K 0001093557-26-000027, segment and revenue notes (XBRL).

Income statement

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue573.3M718.5M1.0B1.5B1.9B2.4B2.9B3.6B4.0B4.7B
Cost of revenue194.9M226.4M367.7M544.5M646.6M768.0M1.0B1.3B1.6B1.9B
Gross profit378.4M492.1M663.9M931.5M1.3B1.7B1.9B2.3B2.4B2.8B
R&D156.1M185.4M199.7M273.5M359.9M517.1M484.2M505.8M552.4M599.1M
SG&A286.2M349.2M432.8M515.7M618.2M810.5M1.0B1.2B1.3B1.3B
Operating income-63.9M-42.5M-186.3M142.3M299.5M265.8M391.2M597.7M600.0M911.8M
Interest expense700K12.8M22.7M60.3M17.7M18.8M18.6M20.3M19.0M18.3M
Pretax income-64.9M-48.6M-126.5M104.2M297.9M256.8M390.8M710.4M709.0M1.1B
Income tax700K1.6M600K3.1M-251.8M39.9M49.6M168.9M132.8M252.1M
Net income-65.6M-50.2M-127.1M101.1M549.7M216.9M341.2M541.5M576.2M836.3M
EPS (diluted)-0.78-0.58-1.441.101.330.530.821.301.422.09
Diluted shares-86.3M88.2M92.3M420.4M428.8M427.5M425.5M412.7M405.5M
Depreciation & amortization15.0M16.1M29.1M48.7M67.1M102.0M155.9M186.0M217.7M251.8M
EBITDA-48.9M-26.4M-157.2M191.0M366.6M367.8M547.1M783.7M817.7M1.2B
Gross margin66.0%68.5%64.4%63.1%66.4%68.6%64.7%63.2%60.5%60.1%
Operating margin-11.1%-5.9%-18.1%9.6%15.5%10.9%13.4%16.5%14.9%19.6%
Net margin-11.4%-7.0%-12.3%6.8%28.5%8.9%11.7%14.9%14.3%17.9%
Revenue growth-+25.3%+43.6%+43.1%+30.5%+27.1%+18.8%+24.5%+11.3%+15.6%
EPS growth----+20.9%-60.2%+54.7%+58.5%+9.2%+47.2%

Balance sheet

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash94.5M441.5M1.1B446.2M817.6M1.1B642.3M566.3M606.1M917.7M
Short-term investments29.2M107.1M92.7M--1.4B1.8B2.2B1.7B-
Receivables101.7M134.3M226.7M286.3M428.5M514.3M713.3M973.9M1.0B1.2B
Inventory45.4M45.2M70.7M119.8M234.7M357.3M306.7M559.6M542.6M629.1M
Current assets280.0M744.7M1.7B2.0B3.4B3.7B3.7B4.4B4.3B4.0B
Property & equipment109.4M145.6M183.1M321.3M515.3M801.8M1.1B---
Goodwill11.3M12.1M18.7M18.6M19.3M26.5M25.7M25.2M22.8M24.2M
Total assets402.8M904.1M1.9B2.4B4.3B4.9B5.4B6.3B6.5B6.3B
Current liabilities102.4M138.9M222.4M360.2M614.1M720.8M1.8B1.6B2.9B2.1B
Total liabilities119.0M484.7M1.3B1.5B2.5B2.9B3.3B4.2B4.4B3.6B
Shareholders' equity283.8M419.4M663.3M882.6M1.6B2.0B2.1B2.1B2.1B2.7B
Retained earnings-621.0M-671.8M-798.9M-695.7M-78.2M138.7M479.9M1.0B1.6B2.4B

Cash flow

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow56.2M92.0M123.2M314.5M475.6M442.5M669.5M748.5M989.5M1.4B
Capital spending55.7M66.0M67.1M180.0M199.0M389.2M364.8M236.6M358.8M363.5M
Free cash flow500K26.0M56.1M134.5M276.6M53.3M304.7M511.9M630.7M1.1B
Stock-based pay (added back)110.8M106.2M101.9M102.7M119.4M113.4M126.5M150.8M170.4M159.6M
Buybacks00100.0M000557.7M688.7M750.0M500.0M
Acquisitions-300K011.3M0030.2M3.9M00-
Debt repaid2.3M0--------
Investing cash flow-55.9M-144.4M-139.8M-1.0B-1.0B-216.1M-521.5M-507.2M-207.5M536.0M
Financing cash flow8.1M399.1M710.4M10.7M912.1M10.4M-552.5M-318.6M-734.8M-1.7B

Stock-based pay and leases

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Stock-based pay (expense)110.8M106.2M101.9M102.7M119.4M113.4M126.5M150.8M170.4M159.6M
Stock-based pay / revenue19.3%14.8%9.9%7.0%6.2%4.6%4.3%4.2%4.2%3.4%
Operating lease cost---12.2M18.4M23.3M22.6M22.9M22.4M21.5M
Operating lease cash paid---14.3M18.3M23.3M26.0M28.1M27.5M28.6M
Finance lease principal paid---500K8.5M9.9M15.5M4.7M13.0M6.9M
Right-of-use assets--071.5M93.3M88.1M80.0M71.4M62.8M77.4M
Operating lease liabilities--40.4M86.0M118.3M119.1M115.1M101.2M87.5M95.0M
Finance lease liabilities--15.9M15.0M62.8M60.3M63.8M63.3M64.9M60.5M

From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.

Next Peers in numbers →